Desenlaces metabólicos y cardiovasculares a largo plazo en pacientes tratados con rituximab por pénfigo

Cely Salamanca, Laura Ximena; Otálvaro Pechene, Angie Giselle; Martínez Ramírez, Gustavo Adolfo; Ortega Sierra, Michael Gregorio.
Rev. virtual Soc. Parag. Med. Int ; 10(2)sept. 2023.
Artículo en Español | LILACS-Express | ID: biblio-1522891

Documentos relacionados

  1. State-of-the-art review of human autoimmune blistering diseases (AIBD).
  2. Trunk-dominant and classic facial pemphigus foliaceus in dogs - comparison of anti-desmocollin-1 and anti-desmoglein-1 autoantibodies and clinical presentations.
  3. Características clínicas de los pacientes con pénfigo en la valoración dermatológica de un hospital de alta complejidad
  4. [Pemphigus vulgaris with exclusive affectation in the esophagus: a case report].
  5. Beneficial effect of oclacitinib in a case of feline pemphigus foliaceus.
  6. A case report of the beneficial effect of oclacitinib in a dog with pemphigus vulgaris.
  7. [Rituximab as treatment for refractory pemphigus in Mexican patients].
  8. [Senear-Usher syndrome (seborrheic pemphigus): An exceptional case].
  9. Comparing Clinical Outcomes of Steroid-Sparing Therapy With Rituximab Versus Rituximab Alone in Pemphigus.
  10. Gefitinib induced Pemphigus Vulgaris with PRIDE complex.